“Molecular & Genetic Alterations May Explain Racial Disparity In Breast Cancer”
(Oct 5) Medical News Today, “Molecular and genetic alterations that cause tumors and drive the course of disease may someday explain the differences in incidence and mortality between African American and European American breast cancer patients.”
“Prognosis on prostate is in the gene”
(Oct 4) Courier Mail reports, “A GENE that gives men with prostate cancer a life-saving clue about whether their disease will spread has been uncovered by Australian scientists.”
“Breakthrough by MUHC researcher has major implications”
(Oct 4) EurekAlert reports, “Eye Health Month is off to an exciting start, with the recent announcement by MUHC researcher Dr. Robert Koenekoop and his colleagues of a breakthrough discovery in the genetics of childhood blindness.”
“Gene May Offer New Lead In Cleft Lip, Palate Research”
(Oct 4) Smile-on.com reports, “The identification of a gene that, when under expressed, can cause cleft lip and palate may offer a new lead in research to prevent one of the most common birth defects worldwide.”
“Chemist's Nobel prize for gene-reading breakthrough”
(last accessed 2/2008)
(Oct 4) NewScientist.com reports, “A chemist who has spent 20 years unravelling the process by which genes are “read” was today awarded the Nobel prize for chemistry.”
“Patient's Genes May Guide Antidepressant Use”
(last accessed 2/2008)
(Oct 3) HealthDay News via healthfinder.gov reports, “New insights into how genes affect an individual's response to particular drugs could someday speed the effective treatment of depression, researchers say.”
“Cigarette Chemical Alters Genes, May Cause Cancer, Study Says”
(Oct. 3) Bloomberg.com reports, “A highly concentrated chemical in cigarette smoke, acrolein, alters genes and may be an important cause of lung cancer, according to a study to appear in the Proceedings of the National Academy of Sciences.”
“UVA studies potential target for skin cancer treatment”
(Oct 3) EurekAlert reports, “When normal skin cells become a melanoma tumor, they sometimes turn on genes not usually found in the skin.”
“Williams Syndrome, the brain and music”
(Oct 3)
EurekAlert reports, “Children with Williams syndrome, a rare genetic disorder, just love music and will spend hours listening to or making music.”
“Cancer Gene Activity Inhibited By Antibiotic”
(Oct 3) Medical News Today reports, “A little-known antibiotic shows early promise as an anti-cancer agent, inhibiting a gene found at higher-than-normal levels in most human tumors, according to researchers at the University of Illinois at Chicago College of Medicine.”
“Molecular atlas provides new tool for understanding estrogen-fueled breast cancer”
(Oct 2) EurekAlert reports, “Lurking in unexplored regions of the human genome are thousands of previously unknown on/off switches that may influence how the growth of breast cancer is driven by estrogen, new research by Dana-Farber Cancer Institute researchers has revealed.”
“'Gene Silencing' Discoverers Win Nobel Prize”
(Oct 2) ScienceDaily reports, “The Nobel Assembly at Karolinska Institutet has awarded The Nobel Prize in Physiology or Medicine for 2006 jointly to Andrew Z. Fire and Craig C. Mello for their discovery of ‘RNA interference -- gene silencing by double-stranded RNA.’”
“Genetic Cause Of Craniofacial Birth Defect Pinpointed By UC Davis Children's Hospital
Researcher”
(Oct 2) Medical News Today reports, “A research team led by a UC Davis Children's Hospital scientist has identified a genetic mutation as the cause of a congenital craniofacial birth defect called cranio-lenticulo-sutural dysplasia.”
“Scientists Use Gene Signatures To Find Treatments For Cancer, Obesity And Alzheimer's
Disease”
(Oct 2) Medical News Today reports, “In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."”
“NHGRI funds assessment of public attitudes about population-based studies on genes and environment”
(Sep 28) News-Medical.Net reports, “The National Human Genome Research Institute (NHGRI) has announced it has awarded $2 million to the Genetics and Public Policy Center of the Berman Bioethics Institute at Johns Hopkins University to conduct a public discussion about future potential large U.S. population-based studies examining the roles of genes and environment in human health.”
“Genetic links to schizophrenia focus of international study”
(Sep 28) EurekAlert reports, “The National Institute of Mental Health has awarded Roel A. Ophoff, Ph.D., assistant professor of human genetics at the David Geffen School of Medicine at UCLA, a $3.8 million grant to lead a four-year genetic study of schizophrenia in collaboration with scientists from the University Medical Center (UMC) Utrecht in the Netherlands.”